
BioPharm International-02-01-2009


How change plays out will depend not only on the new Whitehouse, but on pharma leaders' ability to adapt to changing times.

How to choose a disposable mixing system that fits your particular needs.

QbD for QA? Try a two-step approach

Choosing the right tools to enhance the process.

What the current lack of venture capital means for the CRO market.

With cuts in healthcare, biotech drugs are under scrutiny.

Are disposable bioreactors effective for cell culture?
Advertisement
Advertisement
Trending on BioPharm International
1
Biocon’s Pebrilzo Becomes First Breast Cancer Treatment Biosimilar Approved Under EMA’s Tailored Clinical Approach
2
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
3
AbbVie and DISCO Partner on AND-Gated Bispecifics Designed to Recognize Tumor-Selective Protein Pairs
4
FDA Approves First RNAi Therapeutic for Generalized Myasthenia Gravis
5

